Jerry Z. Yang

Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies

Jerry Z. Yang, Anthony L. Young, Po‐Chang Chiang et al. · Journal of Pharmaceutical Sciences · 2008 · 83 citations

Pharmacokinetic Studies, Nanomedicine, Medicine +8

Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase

Shaun R. Selness, Rajesh Devraj, Balekudru Devadas et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 70 citations · Full text

Drug Target, Signaling Pathway, P38 Map Kinase +12

Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK–MDR1 cell monolayers

Fuxing Tang, Hui Ouyang, Jerry Z. Yang et al. · Journal of Pharmaceutical Sciences · 2004 · 69 citations

Proteinlipid Interaction, Biochemistry, Natural Sciences +12

Evaluation of the Permeation Characteristics of a Model Opioid Peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and Its Cyclic Prodrugs across the Blood-Brain Barrier Using an In Situ Perfused Rat Brain Model

Weiqing Chen, Jerry Z. Yang, Rikke Andersen et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 51 citations

Quantitative analysis of a model opioid peptide and its cyclic prodrugs in rat plasma using high-performance liquid chromatography with fluorescence and tandem mass spectrometric detection

Jerry Z. Yang, K.C Bastian, Randy D Moore et al. · Journal of Chromatography B · 2002 · 41 citations

Model Opioid Peptide, Health Sciences, Biochemistry +11